{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T07:22:27Z","timestamp":1770448947827,"version":"3.49.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Virological Methods"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.jviromet.2017.01.007","type":"journal-article","created":{"date-parts":[[2017,1,16]],"date-time":"2017-01-16T15:17:22Z","timestamp":1484579842000},"page":"46-52","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["A direct quantitative PCR-based measurement of herpes simplex virus susceptibility to antiviral drugs and neutralizing antibodies"],"prefix":"10.1016","volume":"242","author":[{"given":"Dezs\u0151 P.","family":"Vir\u00f3k","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ildik\u00f3","family":"Eszik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T\u00edmea","family":"Mosolyg\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamil","family":"\u00d6nder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Val\u00e9ria","family":"Endr\u00e9sz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katalin","family":"Buri\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jviromet.2017.01.007_bib0005","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1517\/14712598.2015.1084280","article-title":"Talimogene laherparepvec in the treatment of melanoma","volume":"15","author":"Appleton","year":"2015","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.jviromet.2017.01.007_bib0010","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0166-3542(95)00066-6","article-title":"Valacyclovir: a review of its antiviral activity, pharmacokinetic properties, and clinical efficacy","volume":"28","author":"Beutner","year":"1995","journal-title":"Antiviral Res."},{"key":"10.1016\/j.jviromet.2017.01.007_bib0015","doi-asserted-by":"crossref","first-page":"4361","DOI":"10.1128\/JCM.02623-14","article-title":"Rapid and direct detection of herpes simplex virus in cerebrospinal fluid by use of a commercial real-time PCR assay","volume":"52","author":"Binnicker","year":"2014","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jviromet.2017.01.007_bib0020","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.coviro.2016.01.013","article-title":"HSV antivirals\u2014current and future treatment options","volume":"18","author":"Birkmann","year":"2016","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.jviromet.2017.01.007_bib0025","doi-asserted-by":"crossref","first-page":"e0144738","DOI":"10.1371\/journal.pone.0144738","article-title":"Higher throughput quantification of neutralizing antibody to herpes simplex viruses","volume":"10","author":"Blevins","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jviromet.2017.01.007_bib0030","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1136\/jnnp.61.4.339","article-title":"The role of laboratory investigation in the diagnosis and management of patients with suspected herpes simplex encephalitis: a consensus report The EU Concerted Action on Virus Meningitis and Encephalitis","volume":"61","author":"Cinque","year":"1996","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jviromet.2017.01.007_bib0035","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jcv.2004.02.009","article-title":"Antiviral drugs in current clinical use","volume":"30","author":"De Clercq","year":"2004","journal-title":"J. Clin. Virol. Off. Publ. Pan Am. Soc. Clin. Virol."},{"key":"10.1016\/j.jviromet.2017.01.007_bib0040","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1086\/518938","article-title":"Use of long-term suppressive acyclovir after hematopoietic stem-cell transplantation: impact on herpes simplex virus (HSV) disease and drug-resistant HSV disease","volume":"196","author":"Erard","year":"2007","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jviromet.2017.01.007_bib0045","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.mimet.2015.11.010","article-title":"High dynamic range detection of Chlamydia trachomatis growth by direct quantitative PCR of the infected cells","volume":"120","author":"Eszik","year":"2016","journal-title":"J. Microbiol. Methods"},{"key":"10.1016\/j.jviromet.2017.01.007_bib0050","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0166-0934(86)90005-4","article-title":"A rapid microneutralization assay for cytomegalovirus","volume":"14","author":"Gonczol","year":"1986","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.jviromet.2017.01.007_bib0055","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1128\/AAC.42.7.1666","article-title":"Antiherpesvirus activities of (1\u2032S, 2(R)-9-[[1\u2032, 2\u2032-bis(hydroxymethyl)cycloprop-1(-yl]methyl]guanine (A-5021) in cell culture","volume":"42","author":"Iwayama","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jviromet.2017.01.007_bib0060","doi-asserted-by":"crossref","first-page":"4921","DOI":"10.1128\/JVI.03285-13","article-title":"Virologic and immunologic evidence of multifocal genital herpes simplex virus 2 infection","volume":"88","author":"Johnston","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.jviromet.2017.01.007_bib0065","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12985-016-0508-4","article-title":"Development of an HSV-1 neutralization test with a glycoprotein D specific antibody for measurement of neutralizing antibody titer in human sera","volume":"13","author":"Luo","year":"2016","journal-title":"Virol. J."},{"key":"10.1016\/j.jviromet.2017.01.007_bib0070","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1093\/infdis\/148.5.868","article-title":"In vitro sensitivity to acyclovir in genital herpes simplex viruses from acyclovir-treated patients","volume":"148","author":"McLaren","year":"1983","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jviromet.2017.01.007_bib0075","doi-asserted-by":"crossref","first-page":"e0155531","DOI":"10.1371\/journal.pone.0155531","article-title":"Prevalence of intrathecal acyclovir resistant virus in herpes simplex encephalitis patients","volume":"11","author":"Mitterreiter","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jviromet.2017.01.007_bib0080","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jviromet.2017.01.007_bib0085","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0924-8579(01)00323-5","article-title":"Combination of benzo[a]phenothiazines with acyclovir against herpes simplex virus","volume":"18","author":"Mucsi","year":"2001","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.jviromet.2017.01.007_bib0090","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1128\/AAC.00615-10","article-title":"Resistance of herpes simplex viruses to nucleoside analogues: mechanisms, prevalence, and management","volume":"55","author":"Piret","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jviromet.2017.01.007_bib0095","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/nbt.2287","article-title":"Oncolytic virotherapy","volume":"30","author":"Russell","year":"2012","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jviromet.2017.01.007_bib0100","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1128\/jcm.4.1.61-66.1976","article-title":"Plaque reduction neutralization test for human cytomegalovirus based upon enhanced uptake of neutral red by virus-infected cells","volume":"4","author":"Schmidt","year":"1976","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jviromet.2017.01.007_bib0105","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1007\/s11910-013-0414-8","article-title":"Update on herpes virus infections of the nervous system","volume":"13","author":"Steiner","year":"2013","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.jviromet.2017.01.007_bib0110","first-page":"422","article-title":"Antiviral activity of hatay propolis against replication of herpes simplex virus type 1 and type 2","volume":"22","author":"Yildirim","year":"2016","journal-title":"Med. Sci. Monit. Int. Med. J. Exp. Clin. Res."},{"key":"10.1016\/j.jviromet.2017.01.007_bib0115","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1111\/j.1365-4632.2007.03449.x","article-title":"Frequency of acyclovir-resistant herpes simplex viruses isolated from the general immunocompetent population and patients with acquired immunodeficiency syndrome","volume":"46","author":"Ziyaeyan","year":"2007","journal-title":"Int. J. Dermatol."}],"container-title":["Journal of Virological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016609341630708X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016609341630708X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,21]],"date-time":"2022-07-21T21:10:56Z","timestamp":1658437856000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016609341630708X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":23,"alternative-id":["S016609341630708X"],"URL":"https:\/\/doi.org\/10.1016\/j.jviromet.2017.01.007","relation":{},"ISSN":["0166-0934"],"issn-type":[{"value":"0166-0934","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A direct quantitative PCR-based measurement of herpes simplex virus susceptibility to antiviral drugs and neutralizing antibodies","name":"articletitle","label":"Article Title"},{"value":"Journal of Virological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jviromet.2017.01.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}